Related Experiment Video
Updated: Apr 8, 2026

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices
Published on: August 1, 2025
Screening and Prophylaxis for Varices in Children with Liver Disease
Molly A Bozic1, Kanika Puri, Jean P Molleston
1Department of Pediatrics, Section of Pediatric Gastroenterology, Hepatology, and Nutrition, Indiana University School of Medicine, 705 Riley Hospital Drive, ROC 4210, Indianapolis, IN, 46202, USA.
Insights
Preventing esophageal varices bleeding in children with portal hypertension lacks clear guidelines. Beta blockers are not recommended, while endoscopic band ligation shows promise for secondary prophylaxis.
Area of Science:
- Pediatric Gastroenterology
- Hepatology
- Clinical Medicine
Background:
- Esophageal varices are common in children with portal hypertension, posing a significant bleeding risk.
- Current pediatric guidelines for primary and secondary prophylaxis are lacking.
- Adult data support beta blockers and endoscopic band ligation (EBL), but pediatric evidence is limited.
Purpose of the Study:
- To review the evidence for primary and secondary prophylaxis of esophageal varices in children with portal hypertension.
- To evaluate the efficacy of pharmacologic and endoscopic interventions in pediatric populations.
Main Methods:
- Literature review of pediatric studies on variceal prophylaxis.
- Analysis of available data on beta blockers and endoscopic band ligation (EBL).
Main Results:
- Insufficient evidence supports beta blockers for preventing variceal bleeding or rebleeding in children.
- Limited evidence supports EBL for primary prophylaxis, with stronger support for secondary prophylaxis in pediatric patients.
Conclusions:
- There is a critical need for clear pediatric guidelines for esophageal variceal prophylaxis.
- Endoscopic band ligation (EBL) shows potential for secondary prophylaxis in children, warranting further investigation.
- Further randomized controlled trials are necessary but challenging in this pediatric population.
Abstract:
Esophageal varices in children with portal hypertension are quite common. Bleeding from these varices frequently occurs. Prophylactic measures to prevent such bleeding can be undertaken either before ("primary," prompted by a screening endoscopy) or after ("secondary") an initial variceal bleed. There are no clear pediatric guidelines for primary or secondary prophylaxis of esophageal varices. Adult studies clearly support the use of pharmacologic (beta blockers) and endoscopic (endoscopic band ligation, EBL) management for both primary and secondary prophylaxis of esophageal varices in patients with portal hypertension. Pediatric studies are limited. There are inadequate data to recommend use of beta blockers to prevent variceal bleeding or rebleeding in children with portal hypertension. There is very limited support for EBL for primary prophylaxis in children and more compelling support for EBL for secondary prophylaxis. Further randomized controlled studies are needed but are difficult to implement in this vulnerable population.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Esophageal Varices-I: Introduction
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

